Cancer-Homing Toxins
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1973-1985
Author(s):
H. C. Ng and H. E. Khoo
Tissue Transport of Anti-cancer Drugs
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1987-1993
Author(s):
Jan Lankelma
ETS Proteins and MMPs: Partners in Invasion and Metastasis
Journal:
Current Drug Targets
Volume:
3
Page:
359-367
Author(s):
Sadmeet Singh, Jane Barrett, Kenji Sakata, Richard G. Tozer and Gurmit Singh
Trans-Platinum Complexes as Anticancer Drugs: Recent Developments and Future Prospects
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1611-1618
Author(s):
S. Radulovic, Z. Tesic and S. Manic
Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1765-1780
Author(s):
Eric J. Friedman
Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Journal:
Current Gene Therapy
Volume:
2
Page:
307-322
Author(s):
Ingrid J. van Dillen, Nanno H. Mulder, Willem Vaalburg, Erik F.J. de Vries and Geke A.P. Hospers
Transductional Targeting with Recombinant Adenovirus Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
323-339
Author(s):
Valerie Legrand, Philippe Leissner, Arend Winter, Majid Mehtali and Monika Lusky
The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
589-603
Author(s):
L. A. Beltz
Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
605-612
Author(s):
M. Folini, M. Pennati and N. Zaffaroni
How to Inhibit Telomerase Activity for Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
613-626
Author(s):
Satoru Kyo and Masaki Inoue